Interpreting EQA—Understanding Why Commutability of Materials Matters
File version
Author(s)
Miller, W Greg
Panteghini, Mauro
Delatour, Vincent
Berghall, Heidi
MacKenzie, Finlay
Jones, Graham
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
There is a risk to patients of misdiagnosis or incorrect treatment because of bias between results reported from different laboratories/methods for the same measurand. This risk can be identified and hopefully reduced by using External Quality Assurance/Proficiency Testing (EQA/PT) programs when commutable samples are used to identify these differences between laboratories using the same or different methods for the same analyte. Differences may arise due to the traceability of the calibrators, assay imprecision, differences in analytical specificity, and individual laboratory practices.
Journal Title
Clinical Chemistry
Conference Title
Book Title
Edition
Volume
68
Issue
4
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Clinical sciences
Medical biochemistry and metabolomics
Science & Technology
Life Sciences & Biomedicine
Medical Laboratory Technology
Persistent link to this record
Citation
Badrick, T; Miller, WG; Panteghini, M; Delatour, V; Berghall, H; MacKenzie, F; Jones, G, Interpreting EQA—Understanding Why Commutability of Materials Matters, Clinical Chemistry, 2022, 68 (4), pp. 494-500